Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.560
-0.010 (-0.64%)
At close: Apr 23, 2026, 4:00 PM EDT
1.560
0.00 (0.01%)
After-hours: Apr 23, 2026, 7:52 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $2.23 million as of April 23, 2026. Its market cap has decreased by -55.42% in one year.
Market Cap
2.23M
Enterprise Value
-3.64M
1-Year Change
-55.42%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $2.23M, a decrease of -91.54%. That is a compound annual growth rate of -27.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 2.23M | -62.00% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Decoy Therapeutics | 2.88M |
| Virax Biolabs Group | 2.69M |
| HCW Biologics | 2.69M |
| Calidi Biotherapeutics | 2.55M |
| Bone Biologics | 2.52M |
| Biodexa Pharmaceuticals | 2.52M |
| Propanc Biopharma | 2.40M |
| BiomX | 2.28M |